| SC 13G | 2024-04-01 | Logos Global Management LP | NextCure, Inc. | 2,000,460 | 7.2% | EDGAR |
| SC 13D/A | 2024-03-08 | ORBIMED ADVISORS LLC | NextCure, Inc. | 1,268,013 | 4.5% | EDGAR |
| SC 13G/A | 2024-01-19 | MILLENNIUM MANAGEMENT LLC | NextCure, Inc. | 1,140,389 | 4.1% | EDGAR |
| SC 13G/A | 2023-02-06 | Lilly Asia Ventures Fund III, L.P. | NextCure, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2023-01-24 | MILLENNIUM MANAGEMENT LLC | NextCure, Inc. | 1,449,885 | 5.2% | EDGAR |
| SC 13G/A | 2022-02-09 | Lilly Asia Ventures Fund III, L.P. | NextCure, Inc. | 568,129 | 2.1% | EDGAR |
| SC 13G/A | 2021-07-12 | BlackRock Inc. | NextCure, Inc. | 1,204,689 | 3.2% | EDGAR |
| SC 13G/A | 2021-05-10 | MORGAN STANLEY | NextCure, Inc. | 399,919 | 1.4% | EDGAR |
| SC 13G/A | 2021-02-16 | GREAT POINT PARTNERS LLC | NextCure, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-12 | LORD, ABBETT & CO. LLC | NextCure, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-11 | MORGAN STANLEY | NextCure, Inc. | 2,181,618 | 7.9% | EDGAR |
| SC 13G/A | 2021-02-03 | CANAAN X L.P. | NextCure, Inc. | 838,442 | 3.0% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | NextCure, Inc. | 1,514,643 | 5.5% | EDGAR |
| SC 13G | 2020-10-26 | MORGAN STANLEY | NextCure, Inc. | 1,878,980 | 6.8% | EDGAR |
| SC 13G | 2020-02-21 | GREAT POINT PARTNERS LLC | NextCure, Inc. | 1,376,532 | 5.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Cormorant Asset Management, LP | NextCure, Inc. | 936,958 | - | EDGAR |
| SC 13G/A | 2020-02-14 | CITADEL ADVISORS LLC | NextCure, Inc. | - | 2.9% | EDGAR |
| SC 13G | 2020-02-14 | LORD, ABBETT & CO. LLC | NextCure, Inc. | 1,442,300 | 5.4% | EDGAR |
| SC 13G | 2020-02-13 | Lilly Asia Ventures Fund III, L.P. | NextCure, Inc. | 568,129 | 2.1% | EDGAR |
| SC 13G | 2020-02-06 | CANAAN X L.P. | NextCure, Inc. | 2,254,442 | 8.2% | EDGAR |